FRoG: an independent dose and LETd prediction tool for proton therapy at ProBeam® facilities

Purpose Particle therapy is becoming increasingly available world-wide for precise tumor targeting, its favorable depth dose deposition, and increased biological damage to tumor tissue compared to conventional photon therapy. As demand increases for improved robustness and conformality, next-generat...

Full description

Saved in:
Bibliographic Details
Main Authors: Kopp, Benedikt (Author) , Jensen, Maria Fuglsang (Author) , Mein, Stewart (Author) , Hoffmann, Lone (Author) , Nyström, Håkan (Author) , Falk, Marianne (Author) , Haberer, Thomas (Author) , Abdollahi, Amir (Author) , Debus, Jürgen (Author) , Mairani, Andrea (Author)
Format: Article (Journal)
Language:English
Published: 31 July 2020
In: Medical physics
Year: 2020, Volume: 47, Issue: 10, Pages: 5274-5286
ISSN:2473-4209
DOI:https://doi.org/10.1002/mp.14417
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/https://doi.org/10.1002/mp.14417
Verlag, kostenfrei, Volltext: https://aapm.onlinelibrary.wiley.com/doi/abs/10.1002/mp.14417
Get full text
Author Notes:Benedikt Kopp, Maria Fuglsang Jensen, Stewart Mein, Lone Hoffmann, Håkan Nyström, Marianne Falk, Thomas Haberer, Amir Abdollahi, Jürgen Debus, Andrea Mairani

MARC

LEADER 00000caa a2200000 c 4500
001 1744763291
003 DE-627
005 20230428033120.0
007 cr uuu---uuuuu
008 210115s2020 xx |||||o 00| ||eng c
024 7 |a 10.1002/mp.14417  |2 doi 
035 |a (DE-627)1744763291 
035 |a (DE-599)KXP1744763291 
035 |a (OCoLC)1341388821 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kopp, Benedikt  |d 1990-  |e VerfasserIn  |0 (DE-588)1170097081  |0 (DE-627)1037079787  |0 (DE-576)512373809  |4 aut 
245 1 0 |a FRoG: an independent dose and LETd prediction tool for proton therapy at ProBeam® facilities  |c Benedikt Kopp, Maria Fuglsang Jensen, Stewart Mein, Lone Hoffmann, Håkan Nyström, Marianne Falk, Thomas Haberer, Amir Abdollahi, Jürgen Debus, Andrea Mairani 
246 3 3 |a FRoG: an independent dose and LET d prediction tool for proton therapy at ProBeam ® facilities 
264 1 |c 31 July 2020 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.01.2020 
500 |a Im Titel ist der Buchstabe "d" nach LET tiefgestellt 
500 |a Im Titel ist das Registered-Symbol hochgestellt 
520 |a Purpose Particle therapy is becoming increasingly available world-wide for precise tumor targeting, its favorable depth dose deposition, and increased biological damage to tumor tissue compared to conventional photon therapy. As demand increases for improved robustness and conformality, next-generation secondary dose calculation engines are needed to verify treatment plans independently and provide estimates for clinical decision-making factors, such as dose-averaged linear energy transfer (LETd) and relative biological effectiveness (RBE). Method FRoG (Fast dose Recalculation on GPU) has been installed and commissioned at the Danish Centre for Particle Therapy (DCPT). FRoG was developed for synchrotron-based facilities and has previously demonstrated good agreement with gold-standard Monte Carlo simulations and measurements. In this work, additions and modifications to FRoG’s pencil beam algorithm to support the ion beam delivery with cyclotron-based technology as used at the DCPT, range shifter (RS) implementation, and robustness analysis methods are presented. FRoG dose predictions are compared to measurements and predictions of the clinical treatment planning system (TPS) Eclipse (Varian Medical Systems, Palo Alto, United States of America, CA, v.13.7.16) in both homogenous and heterogeneous scenarios using a solid-water/water and a half-head anthropomorphic phantom, respectively. Additional capabilities of FRoG are explored by performing a plan robustness analysis, analyzing dose and LETd for ten patients. Results Mid-target measurements in spread-out Bragg Peaks (SOBP) were on average within −0.19% ± 0.30% and ≤0.5% of FRoG predictions for irradiations without and with RS, respectively. Average 3%/2mm 3D γ-analysis passing rates were 99.1% for 200 patient plan QA comparisons. Measurement with an anthropomorphic head-phantom yielded a γ-passing rate >98%. Overall, maximum target differences in D02% of <2% between the TPS and FRoG were observed for patient plans. The robustness analysis study accounting for range, delivery, and positioning uncertainties revealed small differences in target dose and a maximum LETdVH02% (LETd received by 2% of the volume having dose larger than 1% of maximum dose) values below 10.1 keV/µm to the brain stem. Conclusion We demonstrate that auxiliary dose calculation systems like FRoG can yield excellent agreement to measurements comparable to clinical beam models. Through this work, application of FRoG as a secondary engine at third party cyclotron-based particle treatment facilities is now established for dose verification as well as providing further insight on LETd and variable RBE distributions for protons, currently absent from the standard clinical TPS. 
650 4 |a FRoG 
650 4 |a independent dose engine 
650 4 |a ion-beam therapy 
650 4 |a LETd 
650 4 |a robustness analysis 
700 1 |a Jensen, Maria Fuglsang  |e VerfasserIn  |4 aut 
700 1 |a Mein, Stewart  |d 1989-  |e VerfasserIn  |0 (DE-588)1156925304  |0 (DE-627)1019871873  |0 (DE-576)502506105  |4 aut 
700 1 |a Hoffmann, Lone  |e VerfasserIn  |4 aut 
700 1 |a Nyström, Håkan  |e VerfasserIn  |4 aut 
700 1 |a Falk, Marianne  |e VerfasserIn  |4 aut 
700 1 |a Haberer, Thomas  |d 1960-  |e VerfasserIn  |0 (DE-588)123579198  |0 (DE-627)706353714  |0 (DE-576)214902188  |4 aut 
700 1 |a Abdollahi, Amir  |e VerfasserIn  |0 (DE-588)129612715  |0 (DE-627)474757765  |0 (DE-576)297748874  |4 aut 
700 1 |a Debus, Jürgen  |d 1964-  |e VerfasserIn  |0 (DE-588)1022671421  |0 (DE-627)717025780  |0 (DE-576)365774944  |4 aut 
700 1 |a Mairani, Andrea  |e VerfasserIn  |0 (DE-588)1116742179  |0 (DE-627)870669281  |0 (DE-576)478592493  |4 aut 
773 0 8 |i Enthalten in  |t Medical physics  |d Hoboken, NJ : Wiley, 1974  |g 47(2020), 10, Seite 5274-5286  |h Online-Ressource  |w (DE-627)265784867  |w (DE-600)1466421-5  |w (DE-576)074891243  |x 2473-4209  |7 nnas  |a FRoG: an independent dose and LETd prediction tool for proton therapy at ProBeam® facilities 
773 1 8 |g volume:47  |g year:2020  |g number:10  |g pages:5274-5286  |g extent:13  |a FRoG: an independent dose and LETd prediction tool for proton therapy at ProBeam® facilities 
856 4 0 |u https://doi.org/https://doi.org/10.1002/mp.14417  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://aapm.onlinelibrary.wiley.com/doi/abs/10.1002/mp.14417  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20210115 
993 |a Article 
994 |a 2020 
998 |g 1116742179  |a Mairani, Andrea  |m 1116742179:Mairani, Andrea  |d 50000  |e 50000PM1116742179  |k 0/50000/  |p 10  |y j 
998 |g 1022671421  |a Debus, Jürgen  |m 1022671421:Debus, Jürgen  |d 910000  |d 911400  |e 910000PD1022671421  |e 911400PD1022671421  |k 0/910000/  |k 1/910000/911400/  |p 9 
998 |g 129612715  |a Abdollahi, Amir  |m 129612715:Abdollahi, Amir  |d 910000  |d 911400  |e 910000PA129612715  |e 911400PA129612715  |k 0/910000/  |k 1/910000/911400/  |p 8 
998 |g 123579198  |a Haberer, Thomas  |m 123579198:Haberer, Thomas  |d 910000  |d 950000  |d 950400  |e 910000PH123579198  |e 950000PH123579198  |e 950400PH123579198  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950400/  |p 7 
998 |g 1156925304  |a Mein, Stewart  |m 1156925304:Mein, Stewart  |d 130000  |e 130000PM1156925304  |k 0/130000/  |p 2 
998 |g 1170097081  |a Kopp, Benedikt  |m 1170097081:Kopp, Benedikt  |d 910000  |d 911400  |e 910000PK1170097081  |e 911400PK1170097081  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1744763291  |e 3837354024 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 15.01.2020","Im Titel ist der Buchstabe \"d\" nach LET tiefgestellt","Im Titel ist das Registered-Symbol hochgestellt"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"FRoG: an independent dose and LETd prediction tool for proton therapy at ProBeam® facilities","title":"FRoG: an independent dose and LETd prediction tool for proton therapy at ProBeam® facilities"}],"person":[{"display":"Kopp, Benedikt","given":"Benedikt","role":"aut","family":"Kopp"},{"family":"Jensen","role":"aut","given":"Maria Fuglsang","display":"Jensen, Maria Fuglsang"},{"display":"Mein, Stewart","role":"aut","given":"Stewart","family":"Mein"},{"family":"Hoffmann","role":"aut","given":"Lone","display":"Hoffmann, Lone"},{"display":"Nyström, Håkan","role":"aut","given":"Håkan","family":"Nyström"},{"display":"Falk, Marianne","family":"Falk","given":"Marianne","role":"aut"},{"display":"Haberer, Thomas","given":"Thomas","role":"aut","family":"Haberer"},{"display":"Abdollahi, Amir","family":"Abdollahi","role":"aut","given":"Amir"},{"display":"Debus, Jürgen","family":"Debus","given":"Jürgen","role":"aut"},{"display":"Mairani, Andrea","family":"Mairani","role":"aut","given":"Andrea"}],"relHost":[{"disp":"FRoG: an independent dose and LETd prediction tool for proton therapy at ProBeam® facilitiesMedical physics","recId":"265784867","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Medical physics","title":"Medical physics"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 01.08.2025"],"origin":[{"publisherPlace":"Hoboken, NJ ; College Park, Md. ; New York, NY","dateIssuedKey":"1974","dateIssuedDisp":"1974-","publisher":"Wiley ; AAPM ; [Verlag nicht ermittelbar]"}],"id":{"issn":["2473-4209","1522-8541"],"eki":["265784867"],"zdb":["1466421-5"]},"part":{"pages":"5274-5286","text":"47(2020), 10, Seite 5274-5286","extent":"13","issue":"10","year":"2020","volume":"47"},"name":{"displayForm":["American Association of Physicists in Medicine ; American Institute of Physics"]},"pubHistory":["1.1974 -"],"titleAlt":[{"title":"Medical physics online"}]}],"origin":[{"dateIssuedDisp":"31 July 2020","dateIssuedKey":"2020"}],"physDesc":[{"extent":"13 S."}],"recId":"1744763291","id":{"doi":["10.1002/mp.14417"],"eki":["1744763291"]},"titleAlt":[{"title":"FRoG: an independent dose and LET d prediction tool for proton therapy at ProBeam ® facilities"}],"name":{"displayForm":["Benedikt Kopp, Maria Fuglsang Jensen, Stewart Mein, Lone Hoffmann, Håkan Nyström, Marianne Falk, Thomas Haberer, Amir Abdollahi, Jürgen Debus, Andrea Mairani"]}} 
SRT |a KOPPBENEDIFROGANINDE3120